-
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May 2021 11:52 GMT
… 65 in after-hours trading.
Fluidigm Corporation (NASDAQ: FLDM) … (before the market open)
IPOs
Talaris Therapeutics, Inc., a late … therapy company priced its initial public offering of 8.825 million … substance addiction, priced its IPO of 3 million shares …
-
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
12 Feb 2021 01:23 GMT
… in after-hours trading.
Earnings
Fluidigm Corporation (NASDAQ: FLDM) reported fourth … )
IPOs
Durham, North Carolina-based Bioventus Inc. priced its upsized initial public offering of …
-
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
10 Feb 2021 12:44 GMT
… PACB) (after the market close)
Fluidigm Corporation (NASDAQ: FLDM) (after … (after the market close)
IPOs
French clinical-stage biotech Biophytis … with aging, priced its initial public offering of 1.2 million … system disorders, priced its IPO of $2.25 million …
-
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
06 Feb 2021 23:35 GMT
… PACB) (after the market close)
Fluidigm Corporation (NASDAQ: FLDM) (after … (before the market open)
IPOs
Adagene, Inc., a China-based … ordinary shares, in an initial public offering. The company expects to … 7.53-million-share IPO, with the offering estimated …
-
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q1 2020 Results - Earnings Call Transcript
11 May 2020 06:28 GMT
… available to us, and Fluidigm disclaims any obligation to … institutions are engaging with Fluidigm for immune profiling and … merits additional commentary.
Today, Fluidigm announced the broad commercial … including overseeing a very successful IPO. Pat has been a …
-
Fluidigm Raises USD30 Million in Public Offering of Shares
16 Aug 2017 03:06 GMT
… On August 3, 2017, Fluidigm agreed to issue shares of … On May 2, 2017, Fluidigm filed a registration statement with … Million) 30
Deal Type IPO
Sub-Category Secondary Offering,Completed … Deal Participants
Target (Company) Fluidigm Corp
Deal Rationale
The …
-
Flow Cytometry Market Analysis, Trends and Forecasts, 2023-2024 and 2027 with Executive and Consultant Guides - ResearchAndMarkets.com
29 Mar 2024 17:01 GMT
… .18 Cytek Biosciences Prices $200M Initial Public Offering
6.19 Invivoscribe 12-Color … De Novo Software
7.15 Fluidigm Corp
7.16 Gemini Bio …
-
Outlook On The Flow Cytometry Global Market To 2025 - Move To Cell Based Analytics Is Driving Growth
27 Apr 2022 10:15 GMT
… .10 Cytek Biosciences Prices $200M Initial Public Offering
6.11 Invivoscribe 12-Color … De Novo Software
7.15 Fluidigm Corp
7.16 Gemini Bio …
-
Global Flow Cytometry Market Report With Executive and Consultant Guides and Customized Forecasting to 2025 - ResearchAndMarkets.com
22 Apr 2022 12:24 GMT
…
Cytognos
Cytonome
De Novo Software
Fluidigm Corp
Gemini Bio
Kinetic River … .10 Cytek Biosciences Prices $200M Initial Public Offering
6.11 Invivoscribe 12-Color …
-
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
01 May 2021 18:01 GMT
… PODD) (after the close)
Fluidigm Corporation (NASDAQ: FLDM) (after … (before the market open)
IPOs
IPO Pricing
Valneva SE, a … offering will comprise an initial public offering of ADSs, each representing … ticker symbol ANEB.
IPO Quiet Period Expiry
VectivBio …
About
© 1995-2025